Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Seri Bilgileri: | Бюллетень сибирской медицины |
| Konular: | |
| Online Erişim: | https://bulletin.ssmu.ru/jour/article/view/1618 |